Acidosis: Greenberg & Kass (1958) showed that alkalosis increases the resistance to hypoxia of erythrocytes containing hiemoglobin S and that a crisis could be provoked by an acidosis. A prophylactic alkali regime is, therefore, recommended to reduce the incidence of sickling during anmesthesia. It should probably be used in all cases of sickle cell anemia and hemoglobin SC disease. It does not appear to be necessary in sickle cell trait.
Where oral therapy is possible, tablets of sodium bicarbonate 0 5-1 g/kg/day are suitable for children, or 1 gram t.d.s. for an adult. The urine should be kept alkaline. By intravenous infusion, 3X3 mEq/kg should be given in the first hour. The dosage after this will depend on the renal function of the individual patient and on other intravenous therapy; 100 mEq will usually keep the urine alkaline for six to twelve hours. It may be that an alkaline regime should be continued indefinitely in sickle cell anemia patients (Nwokolo 1960) . Treatment ofa Sickling Crisis For the painful, or occlusive, crisis, analgesics, vasodilators and local heat are used. The use of magnesium sulphate has been suggested as it is a mild vasodilator and anticoagulant. In the postpartum period, Fullerton & Watson-Williams (1962) have shown that if a patient complains of bone pains within three days of delivery, she should be heparinized to prevent fatal marrow embolism in the lungs. They showed this to be a common cause of death in hlmoglobin SC disease.
In a hematological crisis, the hemoglobin may fall with extreme rapidity. Transfusion is required if it falls below 30%.
Conclusion
Because of the large number of Africans and West Indians in this country, we should be aware of this problem and test for sickling before anmsthetizing negroes. There are many hundreds of sicklers living in Britain; the vast majority are heterozygotes (AS) but, with careful treatment, more homozygotes are going to survive infancy, travel abroad from their home countries and find their way on to our operating lists. Here we train many anwsthetists who subsequently practise in Africa, the West Indies, &c. They will find their education sadly lacking if they have not been taught about sickling. I hope that some of them may carefully record their experience and help to clarify the rather vague picture we have at present of the dangers of anesthesia in sickling states and the value of the methods available to minimize them.
The chronic antmia of patients with homozygous hemoglobin S disease is the result of the relative inefficiency with which hemoglobin S is synthesized, the premature removal of red cells from the circulation giving a shortened red cell life and, in some patients, a superimposed deficiency of folic acid. Intravascular destruction of red cells which contain hemoglobin S depends upon the proportion of this hemoglobin present relative to other htmoglobins and the time for which it is allowed to remain in its insoluble reduced form: cells in which nearly all the hemoglobin is reduced hemoglobin S survive for only a few minutes.
Heterozygous patients with hlmoglobin AS have suffered from splenic and other infarcts after unpressurized flying; these incidents are rare. Morbidity after anesthetics has not been a problem, despite an enormous experience in the United States and elsewhere; although the application of tourniquets has been condemned on theoretical grounds, lytic crises have not been reported.
The risk associated with anasthesia in SS patients is not restricted to those who are already anmemic before operation. The hazards of intravascular sludging may even be greater in patients who have a high initial hlemoglobin level, and it is these patients who are likely to show few or no stigmata of their haemoglobinopathy.
Although the AS state gives almost complete protection from lytic crises certain patients heterozygous for hlemoglobin S are not so well protected. In htemoglobin SC disease, the effect of the hemoglobin S is modified to produce few stigmata and mild anmmia but lysis may be severe after operations or in pregnancy. An extra risk arises in patients who are heterozygous for both hemoglobin S and thalassamia; they vary widely in their spontaneous symptoms and degree of anemia. Operations and infection may be accompanied both by intravascular lysis and by aplastic crises, which are unusual in any but severely affected SS patients.
Approximately 25 % of all adult West Africans carry the S gene; at birth about 2% of children are SS, but few survive infancy. The gene is found throughout tropical Africa south to the Zambezi and in certain aboriginal people in Asia: it has spread by migration to many other countries. About 11 % of Jamaicans are AS; correspondingly fewer children are SS but of them relatively many more survive to adult life. Hvmoglobin C had its origin in the Volta valley in West Africa and is found only in people of West African origin. Thalasswmia is found in various forms in tropical Africa, South-East Asia, and the Mediterranean area. S thalassemia, as well as being found in pure-blooded negroes, is not rare in areas of racial admixture between negro and Mediterranean or Asiatic peoples such as the West Indies, South and Central America and the Arabian peninsula and may occur in people who lack obvious negroid characteristics.
Deficiency of the enzyme glucose-6-phosphate dehydrogenase in red cells is a sex-linked recessive abnormality and is found in several forms. Its geographical distribution is much the same as that of thalassemia, probably because both conditions protect against falciparum malaria. A self-limiting attack of hkmolysis may be provoked in male patients and in the rarer homozygous females by a wide range of drugs and other external agents, of which the phenothiazines, vitamin K, quinidine, aspirin, phenacetin and sulphonamides are perhaps the most important in the context of this meeting.
Dr E J Watson-Williams (Department ofClinical Hematology, The University and Royal Infirmary, Manchester)
Preliminary clinical studies suggested that low molecular weight dextran might be valuable in the treatment of patients with bone-pain crises in sickle cell disease. A controlled clinical trial showed, however, that it was of no more benefit than was intravenous infusion of 5 % dextrose in water (Barnes et al. 1965) . Rapid intravenous infusion of any isotonic solution will materially reduce pain in about 50 % of patients. Low molecular weight dextran may be beneficial in other types of crises in sickle cell disease and I still use it in abdominal crises and hmmaturia.
Evidence that patients with sickle cell trait (Hb type AS) are more at risk than normal persons during anesthesia is unconvincing. I know of only two case reports: the first was of death due to longitudinal sinus thrombosis following tonsillectomy in a boy aged 12 but the anesthetic induction was prolonged and complicated (Schenk 1964) . The second death was a child undergoing cardiac surgery and there were other reasons than the anesthetic for hypoxia (Motulsky 1965) . The most convincing evidence against an increased hazard of normal anlesthesia in sickle cell trait is the failure of Brew & Edington (1965) to find any cases of death attributable to this cause in over 2,400 post-mortem examinations in Ibadan, where the incidence of sickle cell trait is 23 %. It is possible that unusual techniques such as hypothermia or extracorporeal circulation in association with anesthesia might be hazardous in persons with sickle cell trait.
A particular problem is emergency surgery when it is impossible to wait for hemoglobin electrophoresis before deciding on the danger of anesthesia. In these circumstances the examination of a peripheral blood film should be sufficient to exclude sickle cell anemia (British Medical Journal 1965) .
Sickle cell diseases are not confined to the negro race. In particular, sickle cell thalassamia occurs amongst the inhabitants of the Middle East, the Indian subcontinent and the Mediterranean area; these persons also should be screened for sickle cell disease before anesthesia.
